Gelteq Ltd (GELS)
Gelteq Ltd is a healthcare company focused on developing and commercializing white-label gel-based delivery solutions for humans and animals. The company’s edible gel products are designed for use with prescription drugs, nutraceuticals, pet care items, and selected sports and over-the-counter products. Its operations are centered in the United States and Australia. Incorporated in 2017, Gelteq Ltd is headquartered in Clayton, Australia. The company’s common stock is listed on the NASDAQ exchange under the ticker GELS.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-GELS
|
$0.68
|
21.7% Upside
|
Undervalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 13, 2026
|
0.6x
|
18.6x
|
6.41 M
|
9.053 M
|
35.9%
|
46.1%
|
-178.2
|
42.5%
|
